Elevated nigral iron levels have been reported in LRRK2 mutation carriers, both in PD patients compared to idiopathic PD and in asymptomatic carriers relative to controls, suggesting that iron accumulation precedes clinical onset in LRRK2-associated PD. Here, LRRK2 is linked to Parkinson disease.